{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042951","form_type":"8-K","ticker":"WGRX","cik":"0002030763","company_name":"Wellgistics Health, Inc.","filed_at":"2026-09-16T21:11:55+00:00","discovered_at":"2026-09-16T21:14:00.436012+00:00","generated_at":"2026-09-16T21:14:12.367731+00:00","sec_items":["1.01","2.03","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"DataMeds acquires Helomics for $1.5M in stock and convertible note, expanding into cancer diagnostics","bullets":["Paid 636,328 shares (~19.99% of MEDS outstanding) plus $1.363M 7% convertible note due Sept 2029; conversion at $1.00/share pending Nasdaq approval.","Helomics brings CLIA/CAP-certified lab, Predictive Oncology CRO, and $1.5M cash; no third-party debt or unpaid payables.","Expands DataMEDS beyond GLP-1 and Long COVID into $40B U.S. cancer diagnostic/treatment market.","Seller Axe Compute (AGPU) retains shareholder stake; agrees to 12-month transfer lock-up and 6-month vote-alignment with DataMeds board.","Deal closed Sept 11, 2026; Helomics becomes wholly owned subsidiary of DataMeds AI."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042951","json":"https://secwatch.observer/filing/0001493152-26-042951.json","markdown":"https://secwatch.observer/filing/0001493152-26-042951.md","text":"https://secwatch.observer/filing/0001493152-26-042951.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226042951/0001493152-26-042951-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226042951/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-16T21:14:12.367731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}